Andrew X. Zhu

Hepatology · 2004–2022

A researcher in the Science corpus: 18 papers; trusts 3 researchers and is trusted by 1 researcher here, as inferred from the citation graph.

Subfields

Whom Andrew X. Zhu trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. J. Llovet
  2. Jordi Bruix1 , 2

Who trusts Andrew X. Zhu overall

  1. J. Llovet
  2. Amit G. Singal
  3. Peter R. Galle

Papers from Andrew X. Zhu's perspective

Ordered by how strongly the researchers Andrew X. Zhu trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. (Gastroenterology)
  2. Novel advancements in the management of hepatocellular carcinoma in 2008. (Journal of Hepatology)
  3. Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics. (Journal of Hepatology)
  4. INCIDENCE OF HEPATOCELLULAR CARCINOMA AND ASSOCIATED RISK FACTORS IN HEPATITIS C-RELATED ADVANCED LIVER DISEASE (Gastroenterology)
  5. The natural history of compensated cirrhosis due to hepatitis C virus: A 17‐year cohort study of 214 patients (Hepatology)
  6. Noninvasive assessment of liver fibrosis (Hepatology)
  7. Prognostic prediction and treatment strategy in hepatocellular carcinoma (Hepatology)
  8. Inhibition of Mutated, Activated BRAF in Metastatic Melanoma (New England Journal of Medicine)
  9. Erlotinib in lung cancer - molecular and clinical predictors of outcome. (New England Journal of Medicine)
  10. Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling (Molecular Cancer Therapeutics)

Their papers